申请人:MERCK & CO INC
公开号:WO2009148887A1
公开(公告)日:2009-12-10
The instant invention provides for substituted [1,2,4]triazolo[4,3-a]-1,5-naphthyridine compounds that inhibit Akt activity. In particular, the compounds disclosed selectively inhibit one or two of the Akt isoforms, preferably Akt1. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting Akt activity, especially Akt1 by administering the compound to a patient in need of treatment of cancer.
该瞬时发明提供了取代的[1,2,4]三唑并[4,3-a]-1,5-萘啶化合物,可以抑制Akt活性。具体来说,所披露的化合物选择性地抑制Akt同工酶中的一个或两个,最好是Akt1。该发明还提供了包含这种抑制化合物的组合物以及通过向需要癌症治疗的患者施用该化合物来抑制Akt活性的方法。